Physician profile
Alice O Johnson
NPI 1356324479
$2,716.64
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,233 · 2020: $607 · 2021: $825 · 2022: $51.39.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $747.13 | 2019-2022 | |
| Janssen Biotech, INC. | $369.97 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $351.35 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $348.47 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $203.80 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $105.99 | 2019 | |
| Ironwood Pharmaceuticals, INC | $100.44 | 2019-2021 | |
| Ucb, INC. | $99.17 | 2019-2021 | |
| Daiichi Sankyo INC. | $74.21 | 2019-2021 | |
| Nestle Healthcare Nutrition INC. | $70.63 | 2020-2021 | |
| Pfizer INC. | $68.83 | 2019-2022 | |
| Gilead Sciences, INC. | $32.27 | 2019-2020 | |
| Redhill Biopharma INC. | $26.79 | 2020-2021 | |
| Shire North American Group INC | $20.43 | 2019 | |
| Boston Scientific Corporation | $17.93 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16.98 | 2019 | |
| Braintree Laboratories, INC. | $14.47 | 2020 | |
| Alfasigma USA, INC. | $14.08 | 2020 | |
| Intra-Sana Laboratories | $12.98 | 2022 | |
| Vivus LLC | $12.65 | 2021 | |
| Endogastric Solutions, INC | $8.07 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.